Intratech Is Developing The Boostera C Spiral Balloon For The Semi Occlusion Of The Coronary Sinusto Improve The Efficacy Of Coronary Intervention For Ami Patients Around 16 Million People Worldwide Have A Heart Attack Every Yearup To 30Of Patients With Acute Myocardial Infarctionamiwill Develop Heart Failure Which Has A Huge Impact On Overall Health And Patient Quality Of Life After The Revascularization Of The Clogged Arterythe Boostera C Balloon Is Placed In The Coronary Sinus Veinand Due To Its Unique Spiral Designit Increases Vascular Pressurethis Elevated Pressure Enhances Blood Perfusion Into The Affected Myocardiumimproving The Patient S Cardiac Functionintratech Has Promising Pre Clinical Results And Has Launched Its First In Human Clinical Trial In 2021The Company Has Secured A Major Investment From A Key Strategic Corporation In The Interventional Cardiology Field And Has A Comprehensive Patent Family With Patents Granted Globally
